drugset / Trial / NCT03432468

Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women

NCT03432468

Unknown 102 enrolled LanZhou University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compared the improvements of blood pressure levels, left ventricular hypertrophy, left ventricular diastolic function, vascular function and cognitive function between postmenopausal hypertensive women and age-matched hypertensive male patients through the evaluation of the effects of fully blocked AT1 receptor by valsartan. Additionally, the differences of the above indexes between the patients who were fully blocked AT1 receptor by valsartan and the patients who were treated with a single dose of valsartan treatment were assessed, so as to provide theory basis for clinical treatment of postmenopausal hypertensive women.

Timeline

Start
2018-04-01
Primary completion
2019-08-01
Completion
2019-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Valsartan Small molecule 80 mg

Indications